Skip to main content
HLB PANAGENE Co., LTD. logo

HLB PANAGENE Co., LTD. - Investor Relations & Filings

Listed IPO Aug 2000
Ticker · 046210 ISIN · KR7046210001 KO Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2026-03-25 Declaration of Voting R…
Country KR South Korea
Listing KO 046210 · 1 venue

About HLB PANAGENE Co., LTD.

https://www.hlbpanagene.com/

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document provides the full results of an Annual General Meeting (정기주주총회결과), including approval of financial statements, election/re-election of directors and auditors, and detailed voting percentages for each agenda item. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-25 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 91% confidence The document is a formal notice to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사). It details dates of change, names, terms, and reasons for board member changes. This clearly falls under announcements of changes in the company’s board of directors, matching the Board/Management Information category.
2026-03-25 Korean
기업설명회(IR)개최
Investor Presentation Classification · 90% confidence The document is a short announcement of an upcoming corporate investor relations presentation (IR Day) with date, time, location, purpose, and logistics. It is not a financial report itself, nor an earnings release or regulatory notice of voting or dividends. The content clearly pertains to arranging an Investor Presentation event. Therefore, it fits the “Investor Presentation” category (Code: IP).
2026-03-25 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is an announcement of an upcoming investor relations meeting (“기업설명회(IR) 개최”), providing date, time, location, target audience, purpose and how the IR materials will be posted. This is not a financial report or earnings release, but specifically an Investor Presentation event notice. Therefore it best fits the “Investor Presentation” category (IP).
2026-03-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a mandatory disclosure for directors and major shareholders regarding their personal share transactions (insider trading). Based on the provided categories, this corresponds to 'Director's Dealing' (DIRS).
2026-03-18 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 98% confidence The document is a comprehensive 'Audit Report' (감사보고서) for HLB Panagene Inc., covering the fiscal years 2024 and 2025. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. While it contains financial statements, it is explicitly titled as an 'Audit Report' and includes the auditor's opinion, making it a standalone audit document rather than a full 10-K annual report. FY 2025
2026-03-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.